Sampathkumar Rangasamy

ORCID: 0000-0003-2151-9162
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Genetics and Neurodevelopmental Disorders
  • Genomics and Rare Diseases
  • Retinal Imaging and Analysis
  • RNA modifications and cancer
  • RNA Research and Splicing
  • Lipid metabolism and disorders
  • Epigenetics and DNA Methylation
  • Advanced Glycation End Products research
  • Fetal and Pediatric Neurological Disorders
  • Pancreatic function and diabetes
  • Angiogenesis and VEGF in Cancer
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Diabetes and associated disorders
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Sphingolipid Metabolism and Signaling
  • Ubiquitin and proteasome pathways
  • Atherosclerosis and Cardiovascular Diseases
  • RNA regulation and disease
  • Natural Antidiabetic Agents Studies
  • Prenatal Screening and Diagnostics
  • RNA and protein synthesis mechanisms
  • Glaucoma and retinal disorders
  • Retinal Development and Disorders
  • Autism Spectrum Disorder Research

Translational Genomics Research Institute
2015-2024

Phoenix (United States)
2024

University of Alabama at Birmingham
2022

Fondazione Santa Lucia
2021

Inserm
2021

University of California, Los Angeles
2020

University of Southern California
2020

University of Iowa
2020

Columbia University
2020

Providence Sacred Heart Medical Center
2020

Most anti-vascular endothelial growth factor (VEGF) therapies in diabetic macular edema are not as robust proliferative retinopathy. Although the VEGF appears to be a good target edema, anti-VEGF appear of transient benefit recurs within few weeks, and repeated injections necessary. There is new evidence that indicates 'retinal inflammation' an important player pathogenesis common sets inflammatory cytokines upregulated both serum vitreous aqueous samples, subjects with retinopathy, these...

10.4103/0974-9233.92116 article EN Middle East African Journal of Ophthalmology 2012-01-01

Inflammation in the diabetic retina is mediated by leukocyte adhesion to retinal vasculature and alteration of blood-retinal barrier (BRB). We investigated role chemokines BRB diabetes. Animals were made streptozotocin injection analyzed for gene expression monocyte/macrophage infiltration. The CCL2 (chemokine ligand 2) was significantly up-regulated retinas rats with 4 8 weeks diabetes also human endothelial cells treated high glucose flux. Additionally, or intraocular recombinant resulted...

10.1371/journal.pone.0108508 article EN cc-by PLoS ONE 2014-10-20

OBJECTIVE—Zinc transporter eight (SLC30A8) is a major target of autoimmunity in human type 1A diabetes and implicated 2 genome-wide association studies. The nonsynonymous single nucleotide polymorphism (SNP) affecting aa325 lies within the region highest ZnT8 autoantibody (ZnT8A) binding, prompting an investigation its relationship to 1 diabetes. RESEARCH DESIGN AND METHODS—ZnT8A radioimmunoprecipitation assays were performed 421 new-onset diabetic Caucasians using COOH-terminal constructs...

10.2337/db08-0522 article EN cc-by-nc-nd Diabetes 2008-07-01

Although VEGF has been identified as an important mediator of the blood-retinal barrier alteration in diabetic retinopathy, hypothesis for this study was that other molecules, including angiopoietins (Ang-1 and -2), may play a role. The expression analyzed animal model role Ang-2 regulation diabetes-induced alterations vascular permeability characterized.Diabetes induced rats, human retinal endothelial cells (HRECs) were grown media with 5.5 or 30.5 mM glucose. Levels Ang-1 -2 mRNA protein...

10.1167/iovs.10-6386 article EN Investigative Ophthalmology & Visual Science 2011-02-10

Abstract Aminoacyl tRNA synthetases (ARSs) link specific amino acids with their cognate transfer RNAs in a critical early step of protein translation. Mutations ARSs have emerged as cause recessive, often complex neurological disease traits. Here we report an allelic series consisting seven novel and two previously reported biallelic variants valyl-tRNA synthetase ( VARS ) ten patients developmental encephalopathy microcephaly, associated early-onset epilepsy. In silico, vitro, yeast...

10.1038/s41467-018-07953-w article EN cc-by Nature Communications 2019-02-12

Abstract The robust detection of disease-associated splice events from RNAseq data is challenging due to the potential confounding effect gene expression levels and often limited number patients with relevant data. Here we present a novel statistical approach splicing outlier differential analysis. Our tests for differences in percentages sequence reads representing local events. We describe software package called Bisbee which can predict protein-level alterations, key feature lacking many...

10.1038/s41598-021-89938-2 article EN cc-by Scientific Reports 2021-05-24

Rett syndrome is an acquired progressive neurodevelopmental disorder caused by

10.3389/fgeed.2024.1346781 article EN cc-by Frontiers in Genome Editing 2024-03-01

Objective— The mechanisms that regulate the physical interaction of pericytes and endothelial cells effects these interactions on interendothelial cell junctions are not well understood. We determined extent to which vascular could pericyte-endothelial adhesion consequences this disruption might have function barrier. Methods Results— Human retinal microvascular were cocultured with pericytes, effect monolayer resistance expression junction molecules N-cadherin VE-cadherin measured....

10.1161/atvbaha.111.235408 article EN Arteriosclerosis Thrombosis and Vascular Biology 2011-09-23

<ns4:p>Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutation in the X-linked <ns4:italic>MECP2</ns4:italic> gene, encoding methyl-CpG-binding protein 2. We have created mouse model (<ns4:italic>Mecp2</ns4:italic> A140V “knock-in” mutant) expressing recurrent human linked to an mental retardation/Rett phenotype. Morphological analyses focused on quantifying soma and nucleus size were performed primary hippocampus cerebellum granule neuron (CGN) cultures from mutant...

10.12688/f1000research.8156.1 preprint EN cc-by F1000Research 2016-09-08

<ns4:p>Mutations disrupting presynaptic<ns4:italic> </ns4:italic>protein TBC1D24 are associated with a variable neurological phenotype, including DOORS syndrome, myoclonic epilepsy, early-infantile epileptic encephalopathy, and non-syndromic hearing loss. In this report, we describe family segregating autosomal dominant 37-year-old Caucasian female severe phenotype Parkinsonism, psychosis, visual auditory hallucinations, gait ataxia intellectual disability. Whole exome sequencing revealed...

10.12688/f1000research.10588.1 preprint EN cc-by F1000Research 2017-04-24

KIF26B is a member of the kinesin superfamily with evolutionarily conserved functions in controlling aspects embryogenesis, including development nervous system, though its function incompletely understood. We describe an infant progressive microcephaly, pontocerebellar hypoplasia, and arthrogryposis secondary to involvement anterior horn cells ventral (motor) nerves. performed whole exome sequencing on trio identified de novo missense variant, p.Gly546Ser, proband. This variant alters...

10.1002/ajmg.a.40493 article EN American Journal of Medical Genetics Part A 2018-08-27

Abstract The sodium-leak channel NALCN forms a subthreshold sodium conductance that controls the resting membrane potentials of neurons. auxiliary subunits and their functions in mammals are largely unknown. In this study, we demonstrate two large proteins UNC80 UNC79 complex. knockout mice neonatal lethal. C-terminus contains domain interacts with overcomes soma-retention signal to achieve dendritic localization. lacking domain, as found human patients, still supports whole-cell currents...

10.1038/s41467-020-17105-8 article EN cc-by Nature Communications 2020-07-03
Coming Soon ...